Proteomics in animal models of Alzheimer's and Parkinson's diseases. - Wikidata - awgldk - TriplyDB

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

http://www.wikidata.org/entity/Q37071539

about

Viruses and neurodegeneration Recent advances in quantitative neuroproteomics Genomic and proteomic responses to environmentally relevant exposures to dieldrin: indicators of neurodegeneration?Proteomic profiling of the retinal dysplasia and degeneration chick retina.Alterations of brain and cerebellar proteomes linked to Aβ and tau pathology in a female triple-transgenic murine model of Alzheimer's disease.First evidence of overlaps between HIV-Associated Dementia (HAD) and non-viral neurodegenerative diseases: proteomic analysis of the frontal cortex from HIV+ patients with and without dementia.Proteomic identification of carbonylated proteins and their oxidation sites Global cPILOT analysis of the APP/PS-1 mouse liver proteome.A SELDI mass spectrometry study of experimental autoimmune encephalomyelitis: sample preparation, reproducibility, and differential protein expression patterns.Oxidative damage compromises energy metabolism in the axonal degeneration mouse model of X-adrenoleukodystrophy.Modes of Aβ toxicity in Alzheimer's disease.The use of MALDI-MSI in the investigation of psychiatric and neurodegenerative disorders: A review.BACE1 activity impairs neuronal glucose oxidation: rescue by beta-hydroxybutyrate and lipoic acid.Proteomic analysis reveals that the protective effects of ginsenoside Rb1 are associated with the actin cytoskeleton in β-amyloid-treated neuronal cells.Longitudinal study of differential protein expression in an Alzheimer's mouse model lacking inducible nitric oxide synthase.Pharmacogenomics and therapeutic strategies for dementia.Proteomics in Parkinson's disease: current trends, translational snags and future possibilities.Understanding the molecular basis of Parkinson's disease, identification of biomarkers and routes to therapy.Proteomics strategies to analyze HPV-transformed cells: relevance to cervical cancer.New insight into neurodegeneration: the role of proteomics.Proteomic analysis of human substantia nigra identifies novel candidates involved in Parkinson's disease pathogenesis.Proteomic study of the toxic effect of oligomeric Aβ1-42 in situ prepared from 'iso-Aβ1-42'.Similarities in lindane induced alterations in protein expression profiling in different brain regions with neurodegenerative diseases.Motor Function in MPTP-Treated Tree Shrews (Tupaia belangeri chinensis).Ex vivo protective effects of nicotinamide and 3-aminobenzamide on rat synaptosomes treated with Aβ(1-42).Nicotinamide treatment reduces the levels of oxidative stress, apoptosis, and PARP-1 activity in Aβ(1-42)-induced rat model of Alzheimer's disease.Ameliorating effects of combined curcumin and desferrioxamine on 6-OHDA-induced rat mode of Parkinson's disease.Proteomes, Their Compositions and Their Sources.Expression of p97/VCP and ubiquitin during postnatal development of the degenerating rat retina.Neuroprotective effects of alkaloids from Piper longum in a MPTP-induced mouse model of Parkinson's disease.Future Trends in the Pharmacogenomics of Brain Disorders and Dementia: Influence of APOE and CYP2D6 Variants.

P2860

Q26991740-6AC7C29E-684A-4437-83DA-B063D263210E Q27000073-D4032E2C-A95D-4784-9D39-0292FA68EE64 Q28382869-E37993B9-04B3-4014-A6B2-36A275A1672B Q33586379-3B464FE6-EEF3-4D75-A817-58394F97ACB0 Q33835175-563A1FCE-A7E4-4893-A1A1-5EB1CF86A2F2 Q33995872-F0DC2638-6D08-47A6-9A7B-BEA8BE5A1539 Q34118916-1499F2EC-483D-4AF5-9D43-F16F69982E75 Q34459615-6CD47943-4E6C-4266-B6B8-72C9E15CB81B Q34698979-DE681030-1250-4EF1-AB19-9E119630C8F2 Q35193956-EB8D7232-D4D7-4582-AA6D-0E9BF15FD2AD Q35235869-379E96D3-DF36-4CD4-8A13-ACACCABF6573 Q36052708-C2393E30-A7C5-47D6-AF78-2B50A39CF727 Q36109558-D591CCC9-AB3B-40EB-8A45-1B16B395A02E Q37218295-F1811181-FE78-49F3-81F3-F25A5399749B Q37419731-9DB77C96-F918-4595-8FC0-AA7DF74B2A6B Q37592250-84C15E8D-2D4A-459B-8AC6-B9253FE0F9EB Q37685124-091ECDDB-B5B2-4951-8C1A-44AB2393BB06 Q37775037-5B2322D6-D8D7-4930-9B8A-C27424125AA2 Q38151763-EB12117E-6E94-4D4A-8977-CC5A942FFDCE Q38170010-E48A1D85-EB16-48F2-8F3D-C0995E68CA4A Q38437443-7E799B4B-D8AA-4A9C-B873-8FEC2FAFD30D Q39578938-CE2D1521-B300-402A-B775-8B7C8D65853C Q40562480-0BBD2C6D-16AC-4F6D-8968-8B203CB247CC Q42257653-2B745CA7-87A0-4082-AD6A-6A8428CED780 Q46853871-0580B2BD-8393-44FF-B281-6EC6C6B41EF8 Q46979323-43A1E1ED-C058-4C1A-A224-07D0E2A14781 Q48681453-7515C8E0-0EF2-473C-B58B-58D570987290 Q51263649-68A83792-81EB-4BB9-ADB8-2A517E1F2F49 Q51843010-16995C5D-BE32-4F64-A94F-0C7C60F5AEAD Q53549376-18F4A6A9-029D-4437-AFE2-50A40A62ADD3 Q55266735-27239A94-201C-43AB-B8CE-0D4DEC49F32E

P2860

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

http://www.wikidata.org/entity/Q37071539

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 18 July 2008

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

@en

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

@nl

type

label

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

@en

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

@nl

prefLabel

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

@en

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

@nl

P1433

Q37071539-44381CA6-FF62-4C7B-9C77-4B65929BE146

P1476

Q37071539-C01D54B3-2F7D-45E3-8757-C9C578D2AFED

P2860

Q37071539-0019B80A-E3B7-4F9E-AC2C-561073BA54D4

Q37071539-02843129-541C-42CC-AE76-D4DF46CD6C9E

Q37071539-09943A16-7157-4977-8D5D-D270BD15D783

Q37071539-09AA883C-16FD-449C-BFC9-02B496049A57

Q37071539-0C798A1C-606B-42E8-9A54-6D6133F275B7

Q37071539-0EEA1C5C-B21E-4A11-90E9-F395197FE75F

Q37071539-0F14B644-9099-4B75-9692-BE68C32EDF23

Q37071539-10C1C7F6-D529-43AE-8EC5-C1B20CA69D17

Q37071539-139C2852-DB86-4745-B7E8-F348E4A9B618

Q37071539-148A17EE-9AEB-4AEC-98A6-8DB5A4B6FFB8

P304

Q37071539-22B7E1D9-2262-4330-9023-D23F92AA298E

P31

Q37071539-5CEC0ED6-4358-4997-9529-27E19F02BBAB

Q37071539-7070e156-943a-45fb-9f8b-475228ea98be

P356

Q37071539-BE507BFA-E4B8-405B-95B1-49E47AEA307C

P4011

Q37071539-200308A7-C62B-4753-84AE-4E862F2F9E97

P433

Q37071539-5576B5A1-0A6B-4D87-BDAE-F26B78D69A3B

P478

Q37071539-434FD2A0-19D2-4BD9-9B7C-675A7D7E96EE

P50

Q37071539-765C23E8-5A15-4B3E-A4F0-1F60D4B4C9B2

Q37071539-7B959F70-9316-40FA-8123-6A5C13BA4503

Q37071539-DFC317CC-71DB-4E5B-B2BB-B79779D84C16

P577

Q37071539-2D887290-D271-4937-854F-0C00403C9C94

P5875

Q37071539-7BF9BE82-0500-4CA6-B7F2-527CD46E55DB

P698

Q37071539-26D204CB-4589-4F76-AA6A-2200C72329C7

P921

Q37071539-057A4EBE-E11E-44EA-AAEF-0BD6E85400FB

Q37071539-B9402F70-267E-4FDE-9661-5F6E295878E6

P932

Q37071539-9158BBFB-88EF-4896-8210-18A258C818A8

P356

J.ARR.2008.07.003

P1433

Ageing Research Reviews

P1476

Proteomics in animal models of Alzheimer's and Parkinson's diseases.

@en

P2860

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1

Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2

Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism

Hereditary early-onset Parkinson's disease caused by mutations in PINK1

Coronin, an actin binding protein of Dictyostelium discoideum localized to cell surface projections, has sequence similarities to G protein beta subunits

Mutation in the alpha-synuclein gene identified in families with Parkinson's disease

Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families

P304

1-17

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ARR.2008.07.003

http://www.w3.org/2001/XMLSchema#string

P4011

db443a280b522bd6b6fe0a1eaba68045b7d014d6

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

D Allan Butterfield

P577

2008-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23170873

http://www.w3.org/2001/XMLSchema#string

P698

18703168

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

Parkinson's disease

P932

2630427

http://www.w3.org/2001/XMLSchema#string